PP2A-γ Activators

PP2A-γ Activators comprise a suite of chemical compounds that indirectly bolster the functional activity of PP2A-γ through various biochemical pathways. Fostriecin, by its selective inhibition of PP2A, effectively leads to an increase in PP2A-γ activity by maintaining its phosphorylation state which is essential for its active conformation. Similarly, (S)-Cantharidin, Okadaic Acid, Calyculin A, Tautomycin, and Microcystin-LR, all function as phosphatase inhibitors with varying degrees of selectivity towards PP2A, ultimately resulting in the sustained activity of PP2A-γ due to reduced dephosphorylation. Endothall also contributes to the preservation of PP2A-γ activity by reversibly inhibiting its dephosphorylation, ensuring the maintenance of its functional state. Salubrinal's unique mechanism of action through eIF2α dephosphorylation inhibition indirectly augments PP2A-γ activity, showcasing the interconnectivity of signaling pathways in regulating protein function.

Furthermore, the small molecule inhibitor LB-100 is known to modulate PP2A-γ activity by altering subunit interactions, thus contributing to the enhancement of its functional state. Norcantharidin, a structural analog of cantharidin, and Rubratoxin B, with selective PP2A inhibition properties, enhance PP2A-γ activity by preventing its inactivation through targeted inhibition. Lastly, Phenothiazine rounds out this group of activators by inhibiting phosphatase activity and thus may lead to an indirect enhancement of PP2A-γ activity by protecting it from dephosphorylation. Collectively, these PP2A-γ Activators, through their intricate mechanisms of phosphatase inhibition and interaction with phosphorylation states, serve to promote the functional activity of PP2A-γ without directly increasing its expression or requiring direct activation of the protein itself.